Taghizadeh, H.
Müllauer, L.
Furtner, J.
Hainfellner, J. A.
Marosi, C.
Preusser, M.
Prager, G. W.
Article History
Received: 17 May 2019
Accepted: 25 November 2019
First Online: 27 December 2019
Competing interests
: M. Preusser has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Merck Sharp & Dome. G.W. Prager received speaker’s fees from Bayer, Roche, Merck-Serono, Amgen, Servier, Celgene, Shire, MSD, Lilly, and Sanofi-Aventis. M.K. received travel support from Merck, Bayer, Bristol-Myers Squibb, and Roche. All other authors have nothing to declare.